JFG
DCPH

Jefferies Financial Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jefferies Financial Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-822,515
Closed -$12.9M – 1969
2024
Q1 		$12.9M Sell
822,515
-95,000
-10% -$1.46M 0.12% 132
2023
Q4 		$14.8M Buy
917,515
+178,772
+24% +$2.28M 0.1% 150
2023
Q3 		$9.4M Buy
738,743
+308,475
+72% +$4.26M 0.08% 179
2023
Q2 		$6.06M Sell
430,268
-744,850
-63% -$10.7M 0.05% 309
2023
Q1 		$18.2M Buy
1,175,118
+1,000,000
+571% +$16.7M 0.15% 120
2022
Q4 		$2.87M Buy
+175,118
New +$2.85M 0.02% 537

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jefferies Financial Group's DCPH Position: Q2 2024 in Review

Jefferies Financial Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 822,515 shares — an estimated $12.9M sold.

Jefferies Financial Group first reported a position in DCPH in Q4 2022 and held it in 6 quarters. The position peaked at $18.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Jefferies Financial Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 822,515 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12.9M.
  • Jefferies Financial Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Jefferies Financial Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $18.2M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.